 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
 | |  | |  | |  | |  | |  | |  |
| Dr. Jaw-Kang Chang (張肇康 博士): Phoenix Pharmaceuticals, Inc. received from Dr. Jaw-Kang Chang (張肇康 博士) |
| Taiwan Island Village: 台灣島村: Hsinchu (Xinzhu) High School Reminisced 憶竹中 忆竹中 |
| Both founders of Phoenix Pharmaceuticals, Dr. Jaw-Kang Chang and Eng Tau, have been pioneers in the peptide industry for over 30 years. Dr. Chang, co-founder and Research Director of Peninsula Labs for 17 years, has had |
| over 100 scientific publications in the peptide field throughout his career. In 1994, they both made the decision to leave Peninsula and start Phoenix Pharmaceuticals. For the past 12 years, Dr. Chang and his team have carved a path and continue to set the trend for peptide research. Phoenix Pharmaceuticals Inc. specializes in Obesity, Cardiovascular, and Diabetes, providing over 7,000 peptide related products to researchers worldwide. |
